Optoderma takes on global psoriasis
This article was originally published in The Rose Sheet
Executive Summary
Company's products for the treatment of psoriasis will be available in the U.S., Canada and Mexico at the end of the month, it announces Nov. 21. Distribution in the U.S. will follow FDA registration as an over-the-counter drug. Optoderma also will expand to 21 countries in the Middle East around the same time through a distribution agreement with a United Arab Emirates company, firm adds. "Highly effective" Optoderma - which comes in cream, lotion and gel form for various applications - is currently sold throughout Europe, as well as online. In Germany, the product's turnover quintupled between January and September of this year, firm adds...
|
Company's products for the treatment of psoriasis will be available in the U.S., Canada and Mexico at the end of the month, it announces Nov. 21. Distribution in the U.S. will follow FDA registration as an over-the-counter drug. Optoderma also will expand to 21 countries in the Middle East around the same time through a distribution agreement with a United Arab Emirates company, firm adds. "Highly effective" Optoderma - which comes in cream, lotion and gel form for various applications - is currently sold throughout Europe, as well as online. In Germany, the product's turnover quintupled between January and September of this year, firm adds.... |